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Ming-Yue Lee,3,4 Benjamin Stauch,3,4 Thomas A. White,2 Anton Barty,2 Andrew Aquila,7 Mark S. Hunter,7
Mengning Liang,7 Sébastien Boutet,7 Mengchen Pu,8 Zhi-jie Liu,8,9 Garrett Nelson,10 Daniel James,10 Chufeng Li,10
Yun Zhao,10 John C. H. Spence,10 Wei Liu,11 Petra Fromme,11 Vsevolod Katritch,3,4,6 Uwe Weierstall,10
Raymond C. Stevens,3,4,6,9 Vadim Cherezov3,4,5,6,12†Serial femtosecond crystallography (SFX) takes advantage of extremely bright and ultrashort pulses produced
by x-ray free-electron lasers (XFELs), allowing for the collection of high-resolution diffraction intensities from
micrometer-sized crystals at room temperature with minimal radiation damage, using the principle of “diffraction-
before-destruction.” However, de novo structure factor phase determination using XFELs has been difficult so far.
We demonstrate the ability to solve the crystallographic phase problem for SFX data collected with an XFEL using
the anomalous signal from native sulfur atoms, leading to a bias-free room temperature structure of the human A2A
adenosine receptor at 1.9 Å resolution. The advancement was made possible by recent improvements in SFX data
analysis and the design of injectors and delivery media for streaming hydrated microcrystals. This general method
should accelerate structural studies of novel difficult-to-crystallize macromolecules and their complexes.INTRODUCTIONThe recent development of x-ray free-electron lasers (XFELs) is in the
process of transforming macromolecular crystallography for both
structural analysis (1) and time-resolved molecular imaging (2). Ex-
tremely bright and ultrashort x-ray pulses enable high-resolution data
collection from micrometer-sized crystals at room temperature with
minimal radiation damage. Because each crystal is destroyed by a
powerful XFEL pulse, crystallographic data sets are typically collected
using the serial femtosecond crystallography (SFX) approach, in which
microcrystals are delivered to the intersection with the pulsed XFEL
beam in a continuous hydrated stream (3). A fast detector operating at
the XFEL pulse repetition rate collects diffraction images from micro-
crystals intersecting the beam at random orientations. After identifica-
tion of diffraction peaks and indexing, structure factor amplitudes
are determined by averaging reflection intensities measured in each
diffraction pattern over stochastic variables, such as the microcrystal
size and the orientation of individual crystals (4).
Recently developed enhancements to the basic Monte Carlo inte-
gration method enable more accurate data to be obtained from fewer
diffraction patterns (5, 6). Meanwhile, the development of viscouscrystal delivery media and special injectors (7–10) has allowed a
marked reduction in crystal consumption for both membrane and sol-
uble proteins. One of the most successful approaches to date involves
the application of the gel-like lipidic cubic phase (LCP) for growth and
delivery of microcrystals across the pulsed x-ray beam (11–13). The
use of microcrystal injectors bypasses the need for mounting the
crystals, whereas femtosecond-duration x-ray pulses from the FEL ob-
viate cryocooling and extensive crystal optimization for challenging
membrane proteins and their complexes with soluble partners. Com-
bined with the improvements in data processing, this enables the de-
termination of accurate reflection intensities from much smaller
amounts of protein than previously possible.
Most protein structures obtained by SFX so far have been
determined using the molecular replacement (MR) method for solving
the crystallographic phase problem. However, experimental phasing of
XFEL data without using previous models is difficult because all
existing approaches require a very high accuracy of structure factor
amplitude measurements, as compared to MR. The first successful ex-
perimental phasing of SFX data was demonstrated with lysozyme
crystals using single-wavelength anomalous dispersion (SAD) on gad-
olinium, which provides a very strong anomalous signal (14). Recent
attempts to use SAD phasing of SFX data from another test soluble
protein, luciferin-regenerating enzyme, with a more conventional
mercury compound were initially unsuccessful, but the collection of
additional data on native crystals and the use of the SIRAS (single iso-
morphous replacement with anomalous signal) method made it pos-
sible to solve the structure (15). Both of these methods rely on the
incorporation of heavy atoms into protein crystals, which requires ex-
tensive screening of various compounds, many of which are toxic or
suffer from poor solubility. Quite often, efficient incorporation is not
attainable, and using native elements for phasing is therefore prefera-
ble. For example, native copper ions were used to phase SFX data for
copper-nitride reductase (16); however, copper or other heavy atoms
are not widespread in biological macromolecules.1 of 9
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native sulfur atoms, which are ubiquitous in most proteins, was intro-
duced more than 30 years ago (17) but has not been commonly used
for a long time because of the extremely low level of the anomalous
signal and the challenges associated with data collection and process-
ing. During the past decade, the method was revisited and started
gaining popularity because of the advances in synchrotron radiation
sources and in the data processing software (18, 19). However, the
conventional wisdom was that, for this method to be successful, one
needs a nearly perfect, large crystal that diffracts to high resolution
and withstands radiation damage. A few years ago, it was shown that
sulfur SAD phasing could be achieved by averaging data from
multiple weakly diffracting small crystals (20), and an optimized
method for routine sulfur SAD phasing at synchrotron beamlines
was published (21). Recently, successful reports of sulfur SAD phasing
of SFX data for test soluble proteins, lysozyme (22) and thaumatin
(23), have been published. Phasing SFX data from weakly diffracting
crystals of membrane proteins and complexes represents a next level
of difficulty. Here, we demonstrate the ability to automatically solve a
macromolecular structure by native sulfur SAD using SFX data
collected at room temperature from micrometer-sized crystals of the
human A2A adenosine receptor (A2AAR), which belongs to the phar-
maceutically important but difficult-to-crystallize superfamily of G
protein–coupled receptors (GPCRs).RESULTS
Anomalous SFX data were collected at the Coherent X-Ray Imaging
(CXI) end station (24) of the Linac Coherent Light Source (LCLS), as
previously described (11). Microcrystals (average size, 5 × 5 × 2 mm3;
fig. S1) of the A2AAR with apocytochrome b562RIL (BRIL) fused into
its third intracellular loop (A2AAR-BRIL) (25) in complex with the
antagonist ZM241385 were grown (26) and delivered inside LCP using
a viscous medium microinjector (7). An x-ray energy of 6 keV
(wavelength, 2.07 Å) was used as a compromise between the strength
of anomalous scattering from sulfur atoms (K-edge, 2.472 keV), the ef-
ficiencies of the Kirkpatrick-Baez mirrors and of the detector, as well as
the detector-size and wavelength limits on resolution. The sample was
injected within a vacuum chamber to minimize background scattering,
and the XFEL beam was attenuated to ~14% of its full power (~170 mJ
per pulse) to prevent oversaturation of the Cornell-SLAC (Stanford
Linear Accelerator Center) pixel array detector (CSPAD). At this
x-ray energy, the anomalous difference in structure factors is expected
to be less than 1.5% (17), requiring a very high precision of collected
data and therefore a very high multiplicity (many measurements of each
reflection). Within ~17 hours, a total of 7,324,430 images were collected
at 120 images/s, in which 1,797,503 crystal diffraction patterns were
identified using the Cheetah hit finding software (27). We successfully
indexed 593,996 of these hits using the CrystFEL software package (28).
The final reflection list was obtained by merging data from 578,620 in-
dexed patterns using iterative scaling and resulted in a data set at 2.5 Å
resolution. This resolution was limited by the x-ray energy, detector size,
and minimal achievable sample-to-detector distance. To further extend
resolution, we collected additional data at an x-ray energy of 9.8 keV
(wavelength, 1.27 Å). This high-resolution data set was assembled from
72,735 indexed patterns and was truncated at 1.9 Å resolution on the
basis of the correlation coefficient (CC*) >0.5 criterion (table S1).Batyuk et al. Sci. Adv. 2016; 2 : e1600292 23 September 2016The structure was solved with a two-stage sulfur SAD phasing
procedure using the A2A_S-SAD anomalous data set collected at the
x-ray energy of 6 keV. In the first stage, SHELXD (19) was used to
determine the sulfur atom substructure. The A2AR-BRIL construct
contains 24 sulfurs (15 Cys and 9 Met) per 447 residues (Cys+Met
residue content, ~5.4%), including 8 sulfurs engaged in four disulfide
bonds. The resolution cutoff was the most critical parameter for the
successful sulfur atom search, with optimal results obtained at 3.5 Å
resolution (fig. S2A). A scatter plot of SHELXD correlation coefficients
between the observed and calculated E values (CCall/CCweak; fig. S2B)
showed the main cluster of random solutions with a few strong ones,
which were well separated from the main cluster. A sharp drop in the
occupancy of sulfur atoms from 0.72 to 0.42 (fig. S2C) was used as an
indicator for distinguishing 16 correct sulfur atoms (Fig. 1) from five
incorrect ones in the found solution, with CCall/CCweak = 32/12. In
the second stage, the partial sulfur substructure solution found with
SHELXD was used as an input for substructure refinement, log-
likelihood gradient map substructure completion, and phasing with
Phaser EP (29). The resulting phases were improved by density modi-
fication and phase extension using Resolve (30). Although density
modification clearly improved the maps, it was not used at its full
potential because of the absence of noncrystallographic symmetry and
a relatively low solvent content (53%). The model was traced auto-
matically with phenix.autobuild (31) to 59% completeness. The result-
ing model contained all eight receptor helices, with only the BRIL
fusion and some loops missing. The electron density maps at the dif-
ferent stages of the phasing process are shown in Fig. 2. Density forFig. 1. Sulfur peaks in the anomalous difference A2AAR Fourier map.
Sulfur density is contoured at 3 s and overlaid on the A2AAR crystal structure.
Twenty sulfur atoms could be identified from the map. BRIL fusion moiety
containing one ordered sulfur atom (M1033) is not shown. Three sulfurs
(M-24, C-13, andM1058) are disordered and do not have electron density.2 of 9
R E S EARCH ART I C L Ethe ligand ZM241385 became clear after automatic tracing (fig. 2C),
validating the correct structure solution. Subsequently, we tried
running the same diffraction data through an automated structure-
determination pipeline, X2DF, which explores a wide range of settings
(32). Several additional combinations of different parameters were
found to yield structure solutions (fig. S3). The success in the phasing
of SFX S-SAD data has been made possible by recent advances in data
processing software. In particular, the new scaling algorithm introduced
in CrystFEL version 0.6.1 appeared to be critical for improving data
quality and solving the structure. Partiality correction was not neces-
sary to achieve this result, and in fact appeared to slightly decrease the
data quality (fig. S4), and did not lead to structure determination.
The final data set used for the structure solution contained 578,620
indexed patterns. To find the minimum number of indexed patterns
necessary for successful structure determination, we performed
phasing, density modification, and autotracing using data ranging
from 100,000 to 550,000 indexed patterns in 50,000 pattern incre-
ments (fig. S5). All phasing attempts with a number of patterns lower
than 500,000 have failed, even when the correct sulfur atom positions
were used, highlighting the requirement of collecting data with high
multiplicity for accurate calculation of anomalous differences from
weak anomalous sulfur scattering. With 550,000 indexed patterns,
structure determination was straightforward, and autotracing yielded
a 46% complete model with 19 cycles in phenix.autobuild. However,Batyuk et al. Sci. Adv. 2016; 2 : e1600292 23 September 2016with 500,000 indexed patterns, autotracing produced a 36% complete
model with 19 cycles and required twice as many cycles (38 cycles) to
produce a similar model with all receptor helices (53% complete) as
the one obtained from 550,000 patterns.
Reducing the number of indexed patterns also had a negative impact
on the initial sulfur atom search using SHELXD.With 550,000 patterns,
15 sulfur atomswere foundwith the same parameters as for the full data
set.With 500,000 and 450,000 patterns, 14 sulfur atomswere found, but
this required optimization of the search parameters in SHELXD (such
as the resolution cutoff) and increase in the number of trials from 1000
to 5000. With 400,000 patterns, only six sulfur atoms were found after
an extensive search, and with 300,000 patterns and lower, the sub-
structure could not be found.
Because the sulfur content in proteins varies, to analyze the effect of
the number of sulfur atoms in the substructure on the success of
phasing, we consecutively removed the 10 weakest sulfur atoms from
the complete 21-atom substructure and performed phasing, density
modification, and autotracing using the complete data set. With nine
sulfur atoms removed, the phasing was successful with a figure of merit
(FOM) of 0.371 and with 45% of the structure built automatically.
However, the removal of 10 sulfur atoms carried a negative effect,
and no model was produced with 36 cycles of autotracing. Therefore,
in this case, it was possible to solve the structure starting fromas low as
12 sulfur atoms per 447 residues (2.7%).Fig. 2. Improvements in electrondensity at different stages of thephasingprocess. (A) Phaser EPmap. (B) Resolve densitymodifiedmap. (C) Autobuild
autotraced map. Omit electron density around the ligand is shown on the top panels. 2mFo-DFc electron density map for helix III is shown on the bottom
panels. All maps are contoured at 1.0 s.3 of 9
R E S EARCH ART I C L EAfter solving and refining the structure at 2.5Åwith theA2A_S-SAD
data set, the resolution was extended to 1.9 Å using the additional
A2A_High-Res data set collected at 9.8 keV. The final, 1.9 Å room tem-
perature A2AAR-BRIL structure (A2A_S-SAD_1.9) contains 396 of 447
residues (excluding disordered N- and C-terminal tags and one BRIL
loop 1045–1055), the ligand ZM241385, 3 cholesterols, 21 lipids, 1 sodi-
um ion, 1 polyethylene glycol (PEG), and 105 water molecules (table S2
and fig. S6). Alternatively, we solved the structure using MRwith the
A2A_High-Res data set truncated at 1.9 and 2.5 Å. Comparison of the
A2A_S-SAD_2.5 and A2A_MR_2.5 structures (fig. S7) showed minimal
differences as expected, with a root mean square deviation (RMSD) of
0.43 Å for Ca atoms of all resolved residues in the protein (0.60 Å for all
atoms). Discrepancies were mostly observed in the solvent-exposed re-
gions on the protein surface, where side chains of bulky residues adopted
alternative conformations and could not be unambiguously modeled.
Also, the B factor distribution showed no substantial deviations of one
structure from the other (fig. S8). Functionally important protein re-Batyuk et al. Sci. Adv. 2016; 2 : e1600292 23 September 2016gions, such as the ligand-binding pocket and the sodium ion binding site
(25), have very similar quality of electron density maps (fig. S9).
Furthermore, we compared the room temperature A2A_S-SAD_1.9
structure with the previously solved structure of the same protein at a
synchrotronunder cryo-conditions [ProteinData Bank (PDB) ID: 4EIY
(25)]. Both structures overlay very well in the receptor part with an
RMSD of 0.24 Å for all resolved Ca atoms, excluding the BRIL fusion
protein (fig. S10). Most differences are observed in the loop regions of
the receptor and in BRIL, which is tilted out from the receptor, ac-
counting for the larger unit cell dimensions in the room temperature
structure. As expected, the average B factor of the room temperature
structure is ~20 Å2 higher than that of the cryocooled structure;
nevertheless, the relative distribution of B factors in both structures is
very similar, with higher B factor values in the loop regions and on
the protein termini (fig. S11). Similar to the previous results (11), we
observed slight improvements in the strength of most interactions
that involve charged side chains in the room temperature structureFig. 3. Comparison of resolved water molecules between the room temperature XFEL structure (A2A_S-SAD_1.9) and the cryocooled synchro-
tron structure (PDB: 4EIY). (A) Cartoon representation of the XFEL structure with overlaid waters. Water molecules from the XFEL structure are shown as
semitransparent spheres, whereas waters from PDB: 4EYI are shown as dots, colored by location: green, close proximity to ligand (<5 Å); red, sodium ion
pocket (<10 Å); cyan, other regions. (B) Conservation of the water positions between PDB: 4EIY and XFEL structures. For eachwater molecule in PDB: 4EIY,
the distance to the closest water in the XFEL structure is shown on the y axis, whereas its B factor is shown on the x axis. Data points are colored the same
way as in (A). Positions ofwatermolecules canbe considered as conserved if the distancebetween correspondingwatermolecules in two structures is less
than 1 Å.4 of 9
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increased. The current room temperature XFEL structure also pro-
vides important insights into water and ion binding to the receptor
under close to physiological conditions (Fig. 3). A total of 101 ordered
waters that interact with the receptor are observed in the XFEL struc-
ture (compared to 166 waters in PDB: 4EIY), of which 88 waters are
located at the same (within 1 Å distance) positions. Most of the waters
preserved at room temperature have relatively low B factors in both
structures and formmultiple polar contacts with the protein residues.
At the same time, most high–B-factor waters are lost in the XFEL
structure, suggesting that they do not have well-defined bound con-
formations at room temperature. Whereas most of the mobile waters
are located in the intra- and extracellular loop regions of the receptor,
tightly bound waters form two contiguous clusters. The first cluster is
defined by close proximity (5 Å) to the ligand, supporting the notion
that ligand binding is strongly mediated by a network of water inter-
actions (33). The second cluster of waters, highly conserved in class A
GPCRs, fills the binding pocket of the sodium ion, which itself has an
identical position in both structures, emphasizing the stability of the
extensive network of ionic and polar interactions around the sodium
ion, which plays a key role in the receptor activation mechanism (34).DISCUSSION
Compared to the previously reported S-SAD phasing of SFX data for
the soluble proteins lysozyme (22) and thaumatin (23), phasing of
A2AAR data required approximately four times more indexed
patterns (table S4). In addition to lower crystal symmetry and lower
sulfur content, the diffraction power of A2AAR microcrystals is sub-
stantially (one to two orders of magnitude) lower compared to lyso-
zyme crystals of comparable size. At the same time, the background
scattering from an LCP stream 50 mm in diameter, in which A2AAR
microcrystals were delivered, is substantially higher (8) than the
background from a liquid stream 5 mm in diameter used to deliver
thaumatin crystals. These factors, together with potentially lower
isomorphicity of A2AAR microcrystals, contribute to the challenge
of native sulfur phasing of SFX data for difficult membrane proteins.
Here, protein consumption required for de novo phasing was very
reasonable (~2.7 mg) due to the very efficient operation of the LCP
injector (7). Our results that ~600,000 indexed patterns are potentially
sufficient to phase GPCR data starting with 12 ordered sulfur atoms
per 447 residues (2.7%) can be placed in perspective with the fact that
over 88% of all human proteins have Cys and Met residue content
higher than 2.7% (fig. S12). Thus, our report provides an important
reference point reassuring that most human proteins could be phased
by S-SAD for de novo structure determination with XFELs.
Although this experiment took only two shifts (24 hours) of LCLS
beam time, including experiment and sample changeover time, the scar-
city of beam time is definitely currently a limiting factor for all XFEL
experiments including de novo phasing and time-resolved studies. Fu-
ture XFEL sources will have higher pulse repetition rates, enabling the
acquisition of similar amounts of data in much less time. New XFEL
facilities are coming online in the next few years (European XFEL,
SwissFEL, PAL, and LCLS-II), providing additional capacity through
an increased number of beamlines to choose from. New detectors will
also have higher dynamic range, improving the quality of data. Further
developments of the data processing software should result in determi-Batyuk et al. Sci. Adv. 2016; 2 : e1600292 23 September 2016nation of more accurate structure factors from fewer diffraction
patterns. Therefore, we expect that within a few years, native sulfur
phasing with XFELs will become a routine exercise.MATERIALS AND METHODS
Protein expression and purification
Expression and purification of A2AAR construct engineered for crystal-
lization, containing BRIL fusion protein in the third intracellular loop
(A2AAR-BRIL), were done as previously described (25). Briefly,
A2AAR-BRIL was expressed in Spodoptera frugiperda (Sf9) insect cells
for 48 hours at 27°C using recombinant baculovirus at a multiplicity of
infection of 5. Cells were harvested by centrifugation and stored at −80°C
until use.
Frozen insect cell pellets were thawed on ice and disrupted by
dounce homogenization in a hypotonic buffer containing 10mMHepes
(pH 7.5), 10 mM MgCl2, 20 mM KCl, and EDTA-free cOmplete pro-
tease inhibitor cocktail (Roche). Insect cell membranes were collected
by centrifugation at 150,000g for 45 min. Extensive washing of the
isolated raw membranes was performed by repeated dounce homoge-
nization and centrifugation in a high osmotic buffer containing 1.0 M
NaCl, 10 mM Hepes (pH 7.5), 10 mMMgCl2, and 20 mM KCl (three
times) to remove soluble and membrane associated proteins. Purified
membranes were resuspended in a storage buffer containing 10 mM
Hepes (pH 7.5), 10 mM MgCl2, 20 mM KCl, and 20% glycerol, flash-
frozen in liquid nitrogen, and stored at −80°C until further use.
Before solubilization, purifiedmembranes were thawed on ice in the
presence of 4 mM theophylline (Sigma), iodoacetamide (2.0 mg/ml;
Sigma), and EDTA-free cOmplete protease inhibitor cocktail (Roche).
After incubation for 30 min at 4°C, membranes were solubilized by in-
cubation in a buffer containing 50 mMHepes (pH 7.5), 800 mMNaCl,
1% (w/v) n-dodecyl-b-D-maltopyranoside (DDM) (Anatrace), and
0.2% (w/v) cholesteryl hemisuccinate (CHS) (Sigma) for 3 hours at
4°C. The unsolubilized material was removed by centrifugation at
250,000g for 45 min. The supernatant was incubated overnight with
TALON immobilized metal affinity chromatography resin (1 ml of
resin per 1 liter of expression culture; Takara-Clontech) in the pres-
ence of 20 mM imidazole. After overnight binding, the resin was
washed with 10 column volumes of 50 mM Hepes (pH 7.5), 800 mM
NaCl, 10% (v/v) glycerol, 25 mM imidazole, 0.1% (w/v) DDM, 0.02%
(w/v) CHS, 10 mM MgCl2, 8 mM adenosine 5′-triphosphate (Sigma),
and 100 mMZM241385 (Tocris; prepared as 100mM stock in dimethyl
sulfoxide), followed by 5 column volumes of 50 mM Hepes (pH 7.5),
800 mM NaCl, 10% (v/v) glycerol, 50 mM imidazole, 0.05% (w/v)
DDM, 0.01% (w/v) CHS, and 100 mM ZM241385. The receptor was
eluted with 3 ml of elution buffer containing 25 mM Hepes (pH 7.5),
800 mM NaCl, 10% (v/v) glycerol, 220 mM imidazole, 0.01% (w/v)
DDM, 0.002% (w/v) CHS, and 100 mM ZM241385. Purified receptor
was concentrated to~60mg/mlwith a 100-kDamolecular weight cutoff
Amicon concentrator (Millipore). Receptor purity and monodispersity
were analyzed by SDS–polyacrylamide gel electrophoresis and analyti-
cal size exclusion chromatography.
Sample preparation
Concentrated protein samples of A2AAR-BRIL in complex with
ZM241385 were reconstituted into LCP by mixing with molten lipid
using a syringe mixer (35). The protein-LCP mixture contained 40%5 of 9
R E S EARCH ART I C L E(w/w) protein solution, 54% (w/w) monoolein (Sigma), and 6% (w/w)
cholesterol (Sigma). Crystals for SFX data collection were obtained in
Hamilton gas-tight syringes using the following procedure (26). Ap-
proximately 6 ml of protein-laden LCP was injected into a 100-ml sy-
ringe filled with 60 ml of precipitant solution [28% (v/v) PEG-400,
40 mM sodium thiocyanate, and 100 mM sodium citrate (pH 5.0)]
and incubated for 24 hours at 20°C. After crystals had formed, excess
precipitant solution was carefully removed, followed by the addition of
~3 ml of 7.9 MAG (monoacylglycerol) (36). The 7.9 MAG was used to
prevent the appearance of a lipidic lamellar crystal phase due to ra-
pid dehydration and cooling upon injection of LCP into vacuum
(10−4 torr). The microcrystal samples were characterized on site
at LCLS by optical and ultraviolet fluorescence imaging. The average
microcrystal size was 5 × 5 × 2 mm3 (fig. S1).
Anomalous SFX data collection and processing
Experiments were performed using the CXI instrument (24) at the
LCLS at SLAC National Accelerator Laboratory. The LCLS was oper-
ated at a wavelength of 2.07 Å (6.0 keV), delivering individual x-ray
pulses of 45-fs pulse duration and ~1.7 × 1011 photons per pulse focused
into a spot size of approximately 1.5 mm in diameter using a pair of
Kirkpatrick-Baez mirrors. Microcrystals of A2AAR-BRIL/ZM241385
were delivered in the LCP medium using a microextrusion injector
(7) with 50-mm nozzle running at a flow rate of ~220 nl/min. Diffrac-
tion images were recorded at a rate of 7200 patterns/min (120 Hz)
with the 2.3-megapixel CSPAD (64 independent detectors of 194 pix-
els × 184 pixels with a pixel size of 110 × 110 mm2 each tiled to cover
an area of 200 × 200 mm2) (37). Background subtraction and detector
correction were performed with the Cheetah software (27). Pedestal
signal arising from the detector was removed by subtracting an aver-
age dark image from each frame and using unbonded pixels as a shot-
to-shot dark reference for common mode corrections. Hot pixels were
identified and masked. The software was also used to discriminate the
patterns containing crystal diffraction, which were named “hits,” from
the rest of the blank shots by locating pixel clusters that lie above a
given threshold. These images were processed with the CrystFEL
software package (version 0.6.1) (28). The unit cell parameters were
first determined using a subset of the collected data. Subsequent in-
dexing was performed by comparing the resulted unit cell parameters
to the determined ones, allowing a tolerance of 15% in reciprocal
space axis lengths and 3° in reciprocal space angles. The detector ge-
ometry and the sample-to-detector distance were first optimized using
a virtual powder pattern from lysozyme crystals, which were collected
at the beginning of the experiment, and further refined at this stage
using geoptimiser (38). Multiple indexing runs were performed, each
by using finer detector geometry corrections to get the final stream
of processed data. The complete set of scattered intensities was ob-
tained by merging (treating Friedel pairs as separate reflections) and
iteratively scaling all the reflections using partialator (CrystFEL package)
without partiality correction. Specifically, the algorithm first gener-
ates a reference set, averaging the reflections from single diffraction
patterns and applying polarization corrections, followed by apply-
ing linear and Debye-Waller scaling of the diffraction patterns using
least-squares minimization of residuals on a logarithmic scale, similar
to the method previously described (39). Three cycles of scaling were
used to generate the final data set. Through these scaling cycles, 15,376
crystals were rejected because they had either not enough common
reflections with the merged data set to permit scaling or relativeBatyuk et al. Sci. Adv. 2016; 2 : e1600292 23 September 2016Debye-Waller factors greater than 100 Å2 or lower than −100 Å2.
The final A2A_S-SAD data set was truncated at 2.5 Å resolution using
the CC* >0.7 criterion (fig. S4A and table S1).
High-resolution SFX data collection and processing
The high-resolution data set (A2A_High-Res) was collected using a sim-
ilar setup as for the A2A_S-SAD set, except for the x-ray energy of
9.8 keV (1.27Å), and the flux of ~6.4 × 1010 photons per pulse. A total of
948,961 images were collected, 232,283 of which were identified as hits
with the Cheetah program (24.5% hit rate). Of these hits, 72,735 were
successfully indexed and merged using the standard CrystFEL pipeline
of Monte Carlo averaging. The merging procedure was performed
using per-pattern resolution cutoff with the “pushres 1.8” option and
without an additional scaling step. Scaling and partiality refinement
were tested but did not result in any significant improvement of data
quality. The final A2A_High-Res data set was truncated at 1.9 Å resolu-
tion using the CC* >0.5 criterion (table S1).
Structure determination
Integrated and scaled intensities of the A2A_S-SAD data set in CrysFEL
format were converted to the XSCALE (40) format, followed by con-
version to the CCP4 mtz and SHELX formats. Anomalous signal
strength was analyzed with phenix.xtriage (31) and was found to ex-
tend to ~3.6 Å (fig. S2A). The substructure was found with SHELXD
(19) (OS X version 2013/2) using the graphical user interface hkl2map
(41), varying the resolution cutoff from 3.0 to 3.6 Å in 0.1 Å incre-
ments, the Emin from 1.5 to 1.2, the number of sites from 10 to 20,
the number of disulfides from 0 to 4, and the number of trials from
1000 to 5000. A clear drop in occupancy from 0.72 to 0.42 at the
3.5 Å resolution cutoff (fig. S2C) was used as an indicator for the
correct solution. After removing the five low-occupancy atoms, the sub-
structure was used as an input in Phaser EP (29) for log-likelihood
gradient map substructure completion and phasing. The resulting
phases for both enantiomorphs with an FOM of 0.418 and a log-
likelihood gain of 505 were subjected to density modification and
phase extension using Resolve (30) with the mask type “Wang.”
The correct hand was identified by success in autotracing. The model
was traced automatically with phenix.autobuild (31), and it was pos-
sible to build 264 of 447 residues (59%) with R/Rfree = 0.31/0.34.
Alternatively, we applied the automated crystal structure determi-
nation pipeline X2DF for the structure determination. X2DF automat-
ically performs heavy atom search, S-SAD phasing, phase extension,
density modification, and automated model building using different
programs based on the “parameter-space screening” strategy (32). In
the current version of X2DF pipeline, the parameters are different
crystallography programs, such as phenix.autosol or SHELXC/D/E
for heavy atom searching and phasing; DM or Parrot for density mod-
ification; phenix.autobuild, ARP/wARP, or BUCCANEER for model
building; and high-resolution cutoff values and incremental step
values for heavy atom search, phasing, phase extension, number of
heavy atoms, solvent content, space groups, etc. For difficult-to-solve
structures, such as S-SAD phasing, only a limited number of combi-
nations of parameters may lead to successful structure solutions. Tak-
ing advantage of high-performance computer cluster’s parallel
computing power, X2DF pipeline explores a much larger multi-
dimensional parameter space than what a human can do manually.
In this case, the 2.5 Å data set was subjected to the following steps
of structure solution determination using the X2DF pipeline. The6 of 9
R E S EARCH ART I C L Epipeline was configured to use SHELXC/D for sulfur atom substructure
determination, Phaser EP for phasing, DM for phase extension, and
phenix.autobuild for model building. Three-dimensional parameter-
space screening was performed. The three screening parameters were
(i) number of heavy atoms (screening range, 1 to 24 based on the
sequence), (ii) high-resolution limits for heavy atom search (screening
range, 2.5 to 4.0 Å; step, 0.1 Å), and (iii) high-resolution limits for
phasing (screening range, 2.5 to 4.0 Å; step, 0.1 Å). A total of 7843 com-
puting jobs were created, of which 200 jobs returned the correct struc-
ture solutions. The best combination resulted in a structure solution
with 294 of 447 residues (66%) automatically traced, an R value of
28.7%, and an Rfree value of 30.2%. The best number of sulfur sites
in the search was 10; however, SHELX yielded 18 sites, from which
six low-occupancy sites were removed automatically before phase cal-
culation. We observed that multiple combinations of high-resolution
limits for sulfur site search and phasing could lead to structure solu-
tions (fig. S3). The best high-resolution limits for sulfur site search and
phasing were 3.60 and 3.25 Å, respectively. This result demonstrates
that the X2DF pipeline could be used as a powerful tool for S-SAD
structure determination with SFX data.
Structure refinement
The structure was further built and refined by repetitive cycling with
phenix.refine (42) using experimental phase restraints with MLHL
(phased maximum likelihood) target function followed by manual ex-
amination and rebuilding of the refined coordinates with Coot (43).
The final model (A2A_S-SAD_2.5), refined to R/Rfree = 17.4/22.8
against the 2.5 Å A2A_S-SAD data using isotropic ADPs and three
TLS groups consisting of residues −2 to 208, 1001 to 1106, and 219
to 308, contains the complete A2AAR-BRIL construct sequence, except
for an unresolved gap (1045–1055) in one of the BRIL loops, ligand
ZM241385, 3 cholesterol molecules, 20 lipids, and 70 waters. The
overall structure had a good stereochemistry with no Ramachandran
outliers (99.0% in favored and 1.0% in allowed regions), as determined
with MolProbity (44).
Resolution was then further extended to 1.9 Å by refining against
the A2A_High-Res data set while using the same Rfree set, extended to
1.9 Å, and experimental phase restraints from the 2.5 Å A2A_S-SAD
data. The final A2A_S-SAD_1.9 model, refined to R/Rfree = 17.3/20.8
using isotropic ADPs and three TLS groups consisting of residues −2
to 208, 1001 to 1106, and 219 to 308, contains the complete A2AAR-
BRIL construct sequence except for an unresolved gap (1045–1055) in
one of the BRIL loops, ligand ZM241385, 3 cholesterol molecules, 21
lipids, and 105 waters. The overall structure had a good stereochemistry
with no Ramachandran outliers (99.0% in favored and 1.0% in
allowed regions), as determined with MolProbity (44).
In parallel, we applied MR using the previously obtained A2AAR
structure (PDB: 4EIY; without BRIL, ligands, and waters) as a search
model, using the A2A_High-Res data truncated at 1.9 and 2.5 Å res-
olution. The MR structures were refined by repetitive cycling with
phenix.refine (42) using the same Rfree set as for the S-SAD struc-
tures, followed by manual examination and rebuilding of the refined
coordinates with Coot (43). The final refinement was done with
three TLS groups, consisting of residues −2 to 208, 1001 to 1106,
and 219 to 308. The final model was fully completed with no gaps
except missing residues 1044–1055 in BRIL. The overall structure
contained a good stereochemistry with no Ramachandran outliers
(99.0% in favored and 1.0% in allowed regions), as determined byBatyuk et al. Sci. Adv. 2016; 2 : e1600292 23 September 2016MolProbity (44). The crystallographic refinement statistics are
shown in table S2.SUPPLEMENTARY MATERIALS
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